EMICIZUMAB

Course overview

EMICIZUMAB IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF HEMOPHILIA A. IT BELONGS TO THE BISPECIFIC MONOCLONAL ANTIBODY CLASS OF MEDICATIONS. THIS ACTIVITY REVIEWS THE INDICATIONS, MECHANISM OF ACTION, AND ADVERSE EVENTS ASSOCIATED WITH EMICIZUMAB ADMINISTRATION IN THE TREATMENT OF HEMOPHILIA A. THIS ACTIVITY ALSO HIGHLIGHTS DRUG MONITORING AND RELEVANT INTERFERENCES WITH COAGULATION ASSAYS, WHICH ARE PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH HEMOPHILIA A.